| Closed |
SWOG-7931 |
Evaluation of n-AMSA in Metastatic or Advanced Adenocarcinoma of the Stomach and Pancreas |
10/5/1979 |
4/14/1981 |
|
|
Published
|
| Closed |
SWOG-9521 |
Evaluation of Nuclear p53 in Patients with Epithelial Ovarian Cancer Patients Registered to SWOG-8835, Ancillary |
3/1/1996 |
11/1/1998 |
|
|
Published
|
| Closed |
SWOG-8800 |
Evaluation of Pibenzimol in Advanced Pancreatic Adenocarcinoma |
4/1/1988 |
5/1/1989 |
|
|
Published
|
| Closed |
SWOG-8866 |
Evaluation of Piroxantrone in Advanced and Metastatic (Stage IV) Non-Small Cell Lung Cancer |
3/1/1990 |
5/1/1991 |
49% |
|
Published
|
| Closed |
SWOG-9116 |
Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II |
6/1/1992 |
10/1/1993 |
100% |
|
Published
|
| Closed |
SWOG-8936 |
Evaluation of Piroxantrone in Gastric Carcinoma |
11/1/1990 |
6/15/1992 |
77% |
|
Published
|
| Closed |
SWOG-8933 |
Evaluation of Piroxantrone in Pancreatic Adenocarcinoma |
9/1/1990 |
9/15/1991 |
100% |
|
Published
|
| Closed |
SWOG-8945 |
Evaluation of Piroxantrone in Patients with Advanced Renal Cell Carcinoma |
9/1/1990 |
5/1/1991 |
76% |
|
Published
|
| Closed |
SWOG-8932 |
Evaluation of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck |
4/1/1990 |
7/15/2009 |
80% |
|
Published
|
| Closed |
SWOG-8911 |
Evaluation of Piroxantrone in Refractory Carcinoma of the Breast |
7/1/1990 |
5/15/1993 |
72% |
|
Published
|
| Closed |
SWOG-9505 |
Evaluation of Pyrazine Diazohydroxide in Patients with Disseminated Malignant Melanoma and No Prior Chemotherapy, Phase II |
1/1/1996 |
8/15/1997 |
55% |
|
Published
|
| Closed |
SWOG-9045 |
Evaluation of Quality of Life in Patients with Advanced Colorectal Cancer Enrolled on SWOG-8905 |
3/1/1991 |
1/15/1993 |
|
|
Published
|
| Closed |
SWOG-8861 |
Evaluation of Quality of Life in Patients with Clinical Stage A2 or B Adenocarcinoma of the Prostate Enrolled on SWOG-8890 (Int-CR-87-017) |
7/15/1990 |
1/1/1992 |
|
|
|
| Closed |
SWOG-8994 (EST-C-0690) (INT-0086) |
Evaluation of Quality of Life in Patients with Stage C Adenocarcinoma of the Prostate Enrolled on SWOG-8794 (INT-0086) |
2/15/1990 |
1/1/1997 |
|
|
Published
|
| Closed |
SWOG-8999 |
Evaluation of Radiation Treatment Following Surgical Resection of Solitary Brain Metastasis |
8/15/1989 |
12/15/1990 |
4% |
|
|
| Closed |
SWOG-8707 |
Evaluation of Recombinant Gamma Interferon In Renal Cell Carcinoma |
6/1/1987 |
1/1/1988 |
|
|
Published
|
| Closed |
SWOG-8374 |
Evaluation of Sequential Intermediate Dose Continuous Infusion MTX with Citrovorum Rescue and Continuous Infusion of Ara-C as an Induction Regimen for Refractory Diffuse NHL |
8/25/1983 |
10/1/1986 |
|
|
|
| Closed |
SWOG-8240 |
Evaluation of Spiorgermanium (NSC-192965) in the Treatment of Metastatic Malignant Melanoma |
11/14/1983 |
5/31/1986 |
|
|
Published
|
| Closed |
SWOG-8217 |
Evaluation of Spirogermanium (NSC-192965) in Adenocarcinoma of the Prostate |
8/11/1982 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-8239 |
Evaluation of Spirogermanium (NSC-192965) in Central Nervous System Tumors |
1/31/1983 |
|
|
|
Published
|
